SA’s medicines regulator has warned the public not to buy or use products sold online claiming to be glucagon-like peptide 1 (GLP-1) weight loss drugs, saying they pose a health risk.

The SA Health Products Regulatory Authority (Sahpra) said it had identified “a significant number” of websites offering illegal sales of products that claimed to be versions of Novo Nordisk’s semaglutide, better known as Ozempic, or Eli Lilly’s tirzepatide, branded Mounjaro...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.